2 AI Stocks to Buy Before They Soar 80% and 50%, According to Wall Street Analysts

Raymond James raised Nvidia's target to $323 (implying >80% upside) citing inference as a catalyst and integration of Groq LPX, Vera Rubin Ultra and SchedMD to bolster its AI systems platform; Nvidia trades at ~16x forward P/E (fiscal 2028). Barclays raised Micron's target to $675 (implying >50% upside) after strong quarterly results, a first five-year customer agreement and rising memory prices driving gross margins; Micron trades at <8x forward P/E (fiscal 2027). Both analysts highlight structural AI/data-center demand and supply constraints as the primary drivers of large potential upside if their forecasts materialize.

Analysis

Nvidia’s shift from pure-play silicon to an AI systems layer is the structural lever that will drive multiple second-order effects across the stack. Software, inference-specialized IP (Groq), and agent runtimes create recurring revenue and higher gross-margin analogues to enterprise software; even a modest reallocation of revenue mix (e.g., +10–15% recurring mix over 2–3 years) would justify material multiple expansion versus a commodity-GPU multiple. That same architecture play forces hyperscalers to choose between deeper vendor lock-in (benefitting NVDA) or vertically integrating inference accelerators — a binary outcome that will reprice capex plans for AMD/Intel customers and accelerate HBM demand.

Micron sits at the direct beneficiary node of that reconfiguration: HBM and high-density DRAM are structurally less elastic than commodity DRAM because redesign cycles across datacenter hardware are multi-year. If Micron converts a few marquee five-year contracts into 20–30% of revenue, its realized cyclicality could compress dramatically and create genuine free-cash-flow optionality in 12–24 months. Countervailing risks are classic: a sudden industry capex cycle (Samsung/SK Hynix catch-up) or a rapid AI architecture shift away from HBM could invert prices quickly — memory is still binary on supply/demand shocks.

Key catalysts and tail risks are concentrated and time-boxable: NVDA product/platform announcements and large cloud inference procurements (0–12 months) and Micron contract announcements and ASP trends (1–2 quarters to 24 months). Trade-policy/geopolitical hits (export controls, China demand swing) remain low-probability but high-impact tail events that can wipe >30–50% of expected upside across both names if realized within 6–18 months.

Key Decisions for Investors

• NVDA — Size a tactical long (2–3% portfolio) in NVDA shares with downside protection: buy shares and buy a 6–9 month 8–12% OTM put to cap near-term drawdown. R/R: scenario where inference monetization accelerates → 40–80% upside in 12 months; protected downside to ~-12% + cost of put.
• NVDA options spread — For more convex upside, buy a 12–18 month call-debit spread (long-dated call / sell further OTM call) sized 1–2% portfolio. R/R: ~2–3x return if platform thesis accelerates, max loss = premium; constructive around major platform/customer milestones.
• MU — Initiate a 3–4% portfolio position in MU (shares or Jan 2028 LEAP calls) to play HBM tightness and contract-ization. Timeframe 12–24 months; R/R: base case +50–100% if multiple long-term deals and HBM pricing persist, downside -40–60% if memory ASPs reflate downward on oversupply.
• Pair trade — Long MU / Short INTC equal-dollar notional for a 12–24 month trade to express asymmetric exposure to HBM-driven memory tightness vs general CPU/IDM execution risk. R/R: target ~2:1 upside given MU’s leverage to HBM ASPs and INTC’s execution/capex vulnerability; size and hedge for idiosyncratic execution headlines.